about
GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblastsSp3 is a transcriptional activator of the human alpha2(I) collagen geneMediators of fibrosisTenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosisEts proteins in biological control and cancer.Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skinRecent advances in fibroblast signaling and biology in scleroderma.Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts.Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.A role for estrogen receptor-α and estrogen receptor-β in collagen biosynthesis in mouse skin.Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells.HLA-B35 and dsRNA induce endothelin-1 via activation of ATF4 in human microvascular endothelial cells.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.Molecular pathways as novel therapeutic targets in systemic sclerosis.Fibrosis in systemic sclerosis.Role of PDGF in fibrotic diseases and systemic sclerosis.Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skinFli1 is a negative regulator of estrogen receptor α in dermal fibroblastsThe impact of Fli1 deficiency on the pathogenesis of systemic sclerosisGenetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetesHLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells.Noncanonical transforming growth factor beta signaling in scleroderma fibrosisCellular and molecular aspects of vascular dysfunction in systemic sclerosis.The Role of TGF-β Receptors in Fibrosis.The role of endoplasmic reticulum stress and the unfolded protein response in fibrosis.Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway.Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.Helicobacter pylori-induced H,K-ATPase alpha-subunit gene repression is mediated by NF-kappaB p50 homodimer promoter binding.Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway.Interferon-γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) β2.Autocrine transforming growth factor β signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts.Pathogenesis of fibrosis: type 1 collagen and the skin.Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway.Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.
P50
Q24305488-797DA40B-7B9C-438E-970E-8AFE671DF8CBQ24308687-4F74C497-C129-4086-894D-F593AE24629BQ24632332-F5776A78-D64B-4B94-984E-871ED8A3CE43Q28771732-1A1E321D-6E03-4452-9D40-AA02D4B26F06Q33745284-84C8A2B1-D8DD-4BCF-BA8F-E9ADE2836068Q33795658-C0927823-9011-4B7B-9EEE-7CA561340CC6Q35701558-6B02DF04-FAD6-4B1E-A790-BDFDA2FAB020Q35791840-36E00EA6-39BC-404A-B1F3-25CEA92C78C0Q35971150-269BC1DB-D5D4-40CC-B661-4F72D7DB6F8CQ36054237-FAAC80D4-4649-494E-8FEA-75EF4C688608Q36054245-359AED08-75C3-4DBC-9A96-D3BAF22C7990Q36231258-191234CC-7FEC-483B-B422-E1C6D0BCE142Q36413138-8A0CA164-1504-4F4D-8010-4173F6167767Q36528516-595A3FDC-54AF-43FB-9952-AEEC0CEE4133Q36618485-5DBF8147-B12C-4330-9628-FB0485122960Q36888302-7FAAAFA6-8E6D-4B03-82F4-ED852FD0133EQ36961452-D1815148-F43D-4C1D-9DE1-CA1703729025Q37105782-92B521CE-100D-490E-A3AA-1D6084A31B0FQ37265804-72409B26-AF6E-4393-936F-5606F93F85C5Q37280652-9868AD4C-F42A-4FD4-BDB0-90995CF28F23Q37301981-70795440-324D-4C4F-8938-FB6272EA63FBQ37305155-D6C77668-5F46-48A4-A955-1EB43BB7503FQ37310058-7199FAA4-4DBB-4FF1-B043-CD03486D062CQ37332304-718AA583-ABE9-4D44-A1D2-52DA037CE3ADQ37588466-3F19C691-F356-4B08-A2B8-0D2C9D9BD78BQ37768336-3FE70AE2-A5EE-46C3-A7F8-3963A8CCA464Q38026846-B8AD8E78-025B-4127-8679-0311715278FAQ38037352-C71FB315-A8F6-4035-990A-FAA46A786E35Q38312620-A66FD449-2CA7-436A-AAB0-9D06D07A0BB6Q38317794-9D03F727-C549-46BD-ABDA-66FFA1CD7359Q39680723-385C563E-A0EC-425B-BE38-A1044FEC3715Q39918910-C9BCEC71-C24F-440C-8556-0ECD8B4DA36AQ39987550-241A45E1-1044-4E78-9333-3764F9827854Q40023974-982C79D7-26D8-4D27-924F-65CD1DF134A3Q40572900-BB825AB4-5FE3-4CAE-BAE5-3323B91C5823Q41252594-1A2D8697-E307-4616-B4F2-63298100F73AQ41434813-A41B032E-2357-44FA-9B2E-F52001F28AC4Q41735865-CE5980F7-0E65-4FEB-AB4F-06EEBA9EF67EQ42142681-993EE6DA-23CA-4CDD-AAA6-7DDA7EDAC1B2Q42243246-5357B618-A3F0-40F5-ACCD-5267A277BD84
P50
description
Pools onderzoekster
@nl
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Maria Trojanowska
@ast
Maria Trojanowska
@ca
Maria Trojanowska
@cs
Maria Trojanowska
@en
Maria Trojanowska
@es
Maria Trojanowska
@gl
Maria Trojanowska
@hr
Maria Trojanowska
@hsb
Maria Trojanowska
@it
Maria Trojanowska
@nl
type
label
Maria Trojanowska
@ast
Maria Trojanowska
@ca
Maria Trojanowska
@cs
Maria Trojanowska
@en
Maria Trojanowska
@es
Maria Trojanowska
@gl
Maria Trojanowska
@hr
Maria Trojanowska
@hsb
Maria Trojanowska
@it
Maria Trojanowska
@nl
prefLabel
Maria Trojanowska
@ast
Maria Trojanowska
@ca
Maria Trojanowska
@cs
Maria Trojanowska
@en
Maria Trojanowska
@es
Maria Trojanowska
@gl
Maria Trojanowska
@hr
Maria Trojanowska
@hsb
Maria Trojanowska
@it
Maria Trojanowska
@nl
P106
P1412
P1559
Maria Trojanowska
@pl
P21
P27
P31
P3124
P496
0000-0001-9550-7178